Combined modality adjuvant therapy for resected periampullary pancreatic and nonpancreatic adenocarcinoma: A review of studies and experience at the Johns Hopkins Hospital, 1991-2003

Surgical Oncology Clinics of North America

Volumn 13, Issue 4, 2004, Pages 621-638

  Abrams, Ross A ^a   Yeo, Charles J ^b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPYRIDAMOLE; FLUOROURACIL; FOLINIC ACID; MITOMYCIN C;

ADENOCARCINOMA; ALGORITHM; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CHEMOTHERAPY; CLINICAL PROTOCOL; CLINICAL TRIAL; COMPARATIVE STUDY; DIAGNOSTIC PROCEDURE; DIARRHEA; DRUG EFFICACY; DUODENITIS; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FOLLOW UP; GASTRITIS; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TOXICITY; HISTOLOGY; HOSPITALIZATION; HUMAN; LENGTH OF STAY; LIVER TOXICITY; MORBIDITY; MULTIVARIATE ANALYSIS; PANCREAS ADENOCARCINOMA; PANCREATICODUODENECTOMY; PREOPERATIVE EVALUATION; RADIATION DOSE; RADIOSENSITIZATION; REVIEW; RISK ASSESSMENT; SIDE EFFECT; SURGICAL TECHNIQUE; TREATMENT OUTCOME; TUMOR VOLUME; WEIGHT GAIN;

ADENOCARCINOMA; ADULT; AGED; ALGORITHMS; AMPULLA OF VATER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BALTIMORE; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS, PHASE I; COMBINED MODALITY THERAPY; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; PROGNOSIS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 4444340510     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soc.2004.06.004     Document Type: Review

References (39)

1. T.A. Sohn, C.J. Yeo, J.L. Cameron, L. Koniaris, S. Kaushal, and R.A. Abrams Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators Gastrointest Surg J 4 6 2000 567 579
2. J.L. Cameron, H.A. Pitt, C.J. Yeo, K.D. Lillemoe, H.S. Kaufman, and J. Coleman One hundred and forty-five consecutive pancreaticoduodenectomies without mortality Ann Surg 217 5 1993 430 435
3. C.J. Yeo, J.L. Cameron, T.A. Sohn, K.D. Lillemoe, H.A. Pitt, and M.A. Talamini Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes Ann Surg 226 3 1997 248 257
4. C.J. Yeo, J.L. Cameron, K.D. Lillemoe, J.V. Sitzmann, R.H. Hruban, and S.N. Goodman Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients Ann Surg 221 6 1995 721 731
5. S.S. Nitecki, M.G. Sarr, T.V. Colby, and J.A. van Heerden Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann Surg 221 1 1995 59 66
6. M.H. Kalser, and S.S. Ellenberg Pancreatic cancer - adjuvant combined radiation and chemotherapy following curative resection Arch Surg 120 1985 899 903
7. Gastrointestinal Tumor Study Group Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer Cancer 59 1987 2006 2010
8. R.A. Abrams, and L.B. Grochow Adjuvant therapy with chemotherapy and radiation therapy in the management of carcinoma of the pancreatic head Surg Clin North Am 75 5 1995 925 938
9. A. Chakravarthy, and R.A. Abrams Radiation therapy and 5-fluorouracil in pancreatic cancer Semin Radiat Oncol 7 4 1997 291 299
10. R.A. Abrams, and W.H. Isacoff Chemotherapy and radiation therapy in the adjuvant management of pancreatic cancer J.L. Cameron Pancreatic cancer 2001 BC Decker, Hamilton London 153 170
11. W.F. Regine, and R.A. Abrams Adjuvant therapy for pancreatic cancer: back to the future Int J Radiat Oncol Biol Phys 42 1 1998 59 63
12. M.A. Carducci, R.A. Abrams, C.J. Yeo, R.H. Hruban, M.L. Zahurak, and J.L. Cameron Early evaluation of abdominal/hepatic irradiation and 5-fluorouracil/leucovorin infusion after pancreaticoduodenectomy Int J Radiat Oncol Biol Phys 35 1 1996 143 150
13. R.A. Abrams, L.B. Grochow, A. Chakravarthy, T.A. Sohn, M.L. Zahurak, and T.L. Haulk Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma. Survival results and observations regarding patterns of failure, radiotherapy dose, and CA19-9 levels Int J Radiat Oncol Biol Phys 44 5 1999 1039 1046
14. W.H. Isacoff, F.R. Eilber, S.L. Kuchenbecker, A. Jacobs, and O. Taylor Continuous infusion 5-fluorouracil given with calcium leucovorin, dipyridamole and mitomycin-C in patients with advanced colorectal carcinoma J Infus Chemother 4 1994 107 111
15. K.E. Todd, B. Gloor, J.S. Lane, W.H. Isacoff, and H.A. Reber Resection of locally advanced pancreatic cancer after downstaging with continuous-infusion 5-fluorouracil, mitomycin-C, leucovorin, and dipyridamole J Gastrointest Surg 2 2 1998 159 166
16. E.M. Jaffee, R. Abrams, J. Cameron, R. Donehower, M. Duerr, and J. Gossett A phase I clinical trial of lethally irradiated allogeneic pancreatic tumor cells transfected with the GM-CSF gene for the treatment of pancreatic adenocarcinoma Hum Gene Ther 9 13 1998 1951 1971
17. E.M. Jaffee, R.H. Hruban, B. Biedrzycki, D. Laheru, K. Schepers, and P.R. Sauter Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activation J Clin Oncol 19 1 2001 145 156
18. C.J. Yeo, R.A. Abrams, L.B. Grochow, T.A. Sohn, S.E. Ord, and R.H. Hruban Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival: a prospective, single institution experience Ann Surg 225 1997 621 636
19. A. Chakravarthy, R.A. Abrams, C.J. Yeo, L.T. Korman, R.C. Donehower, and R.H. Hruban Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival Int J Radiat Oncol Biol Phys 48 4 2000 1089 1096
20. R.A. Abrams, T.A. Sohn, M.L. Zahurak, L.T. Korman, K.D. Lillemoe, and E.M. Jaffee A multivariate model for identifying risk of early death after pancreaticoduodenectomy and adjuvant therapy for periampullary adenocarcinoma: importance for understanding post treatment outcomes Int J Radiat Onco Biol Phys 54 2Suppl 2002 100 101
21. J. Tepper, G. Nardi, and H. Suit Carcinoma of the pancreas: review of MGH experience from 1963-1973 - analysis of surgical failure and its implications for radiation therapy Cancer 37 1976 1519 1524
22. J.F. Griffin, S.R. Smalley, W. Jewell, J.C. Paradelo, R.D. Reymond, and R.E. Hassanein Patterns of failure after curative resection of pancreatic carcinoma Cancer 66 1990 56 61
23. C. Heidelberger, L. Griesbach, and B.J. Montag Studies on fluorinated pyrimidines. II. Effects on transplanted tumors Cancer Res 18 1958 305 317
24. C.G. Moertel, S. Frytak, R.G. Hahn, M.J. O'Connell, R.J. Reitemeier, and J. Rubin Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5- fluorouracil) and high dose radiation + 5-fluorouracil. The Gastrointestinal Tumor Study Group Cancer 48 1981 1705 1710
25. Gastrointestinal Tumor Study Group Treatment of locally unresectable carcinoma of the pancreas: comparison of combined modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone J Natl Cancer Inst 80 1998 751 755
26. J.H. Klinkenbijl, J. Jeekel, and T. Sahmoud Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region Phase III trial of the EORTC Gastrointestinal Tract Cancer Cooperative Group Ann Surg 230 1999 776 784
27. Gastrointestinal Tumor Study Group Prolongation of the disease free interval in surgically treated rectal carcinoma N Engl J Med 312 1985 1465 1472
28. J.S. Macdonald, S.R. Smalley, J. Benedetti, S.A. Hundahl, N.C. Estes, and G.N. Stemmermann Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction N Engl J Med 345 10 2001 725 730
29. E. Bajetta, R. Buzzoni, L. Mariani, E. Beretta, F. Bozzetti, and G. Bordogna Adjuvant chemotherapy in gastric cancer: 5-year results of a randomised study by the Italian Trials in Medical Oncology (ITMO) Group Ann Oncol 13 2002 299 307
30. J. Ragaz, S.M. Jackson, N. Le, I.H. Plenderleith, J.J. Spinelli, and V.E. Basco Adjuvant radiotherapy and chemotherapy in node positive premenopausal women with breast cancer N Engl J Med 337 14 1997 956 962
31. M. Overgaard, P.S. Hansen, J. Overgaard, C. Rose, M. Andersson, and F. Bach Postoperative radiotherapy in high risk premenopausal women with breast cancer who received chemotherapy N Engl J Med 337 14 1997 949 955
32. M. Overgaard, M.B. Jensen, J. Overgaard, P.S. Hansen, C. Rose, and M. Andersson Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial Lancet 353 9165 1999 1641 1648
33. P. Warde, and D. Payne Does thoracic irradiation improve survival and local control in limited stage small cell carcinoma of the lung? A meta analysis J Clin Oncol 10 1992 890 895
34. J.P. Pignon, R. Arriagada, D.C. Ihde, D.H. Johnson, M.C. Perry, and R.L. Souhami A meta-analysis of thoracic radiotherapy for small cell lung cancer N Engl J Med 327 1992 1618 1624
35. T.P. Miller, S. Dahlberg, J.R. Cassady, D.J. Adelstein, C.M. Spier, and T.M. Grogan Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate and high grade non-Hodgkin's lymphoma N Engl J Med 339 1998 21 26
36. J.P. Neoptolemos, J.A. Dunn, D.D. Stocken, J. Almond, and Link K, Beger H Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial Lancet 358 2001 1576 1585
37. R.A. Abrams, K.D. Lillemoe, and S. Piantadosi Continuing controversy over adjuvant therapy of pancreatic cancer Lancet 358 2001 1565
38. J.P. Neoptolemos, D.D. Stocken, H. Friess, C. Bassi, J.A. Dunn, and H. Hickey A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer N Engl J Med 350 12 2004 1200 1210
39. K.E. Bakkevolo, B. Amesjo, O. Dahl, and O. Kambestad Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of vater - results of a controlled prospective, randomized multicenter study Eur J Cancer 29A 5 1993 698 703